BRIEF-NantKwest and Viracta Therapeutics report series B financing

* NantKwest and Viracta Therapeutics announce series b financing and immunotherapy partnership
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.